Flow Cytometric MRD Assessment in Acute Lymphoblastic Leukemias
Sign Up to like & getrecommendations! Published in 2023 at "Indian Journal of Medical and Paediatric Oncology"
DOI: 10.1055/s-0043-1766137
Abstract: Abstract Acute lymphoblastic leukemia (ALL) is one of the very first malignancy where the assessment of early response to therapy by minimal/measurable residual disease (MRD) monitoring has proven to be cardinal tool for guiding therapeutic… read more here.
Keywords: flow cytometric; mrd assessment; cytometric mrd; acute lymphoblastic ... See more keywords
Standardization of flow cytometric minimal residual disease assessment in international clinical trials. A feasibility study from the European Myeloma Network
Sign Up to like & getrecommendations! Published in 2020 at "Haematologica"
DOI: 10.3324/haematol.2020.267831
Abstract: For many decades, international collaborative efforts have driven therapeutic advances in multiple myeloma (MM). The establishment of uniform response criteria by the International Myeloma Working Group (IMWG) has been pivotal for this progress, as adherence… read more here.
Keywords: assessment; myeloma; mfc mrd; mrd assessment ... See more keywords
Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12082322
Abstract: In order to meet the challenges in data evaluation and comparability between studies in multiple myeloma (MM) minimal residual disease (MRD) assessment, the goal of the current study was to provide a step-by-step evaluation of… read more here.
Keywords: mrd; multiple myeloma; mrd assessment; ngs mfc ... See more keywords